Copyright © 2012 Haran Yogasundaram et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Developing vehicles for the delivery of therapeutic molecules, like siRNA, is an area of active research. Nanoparticles composed of bovine serum albumin, stabilized via the adsorption of poly-L-lysine (PLL), have been shown to be potentially inert drug-delivery vehicles. With the primary goal of reducing nonspecific protein adsorption, the effect of using comb-type structures of poly(ethylene glycol) (1 kDa, PEG) units conjugated to PLL (4.2 and 24 kDa) on BSA-NP properties, apparent siR...
Because nanoparticles with diameters less than 50 nm penetrate stromal-rich tumor tissues more effic...
According to the National Institute of Environmental Health Sciences in 2016, more than five million...
Small interfering RNA (siRNA) targeted therapeutics (STT) offers a compelling alternative to traditi...
Copyright © 2012 Haran Yogasundaram et al. This is an open access article distributed under the Crea...
Developing vehicles for the delivery of therapeutic molecules, like siRNA, is an area of active rese...
Developing vehicles for the delivery of therapeutic molecules, like siRNA, is an area of active rese...
Gene regulation through small interfering RNA (siRNA) is a useful way to improve therapeutics and tr...
Therapeutics such as proteins, small interfering RNA (siRNA) and DNA can only exert their function w...
Due to their biodegradable character, polyesters such as polycaprolactone (PCL), poly(D,L-lactide) (...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
The potential of RNA interference (RNAi)-based therapeutics for cancer has received much attention; ...
Purpose: In order to improve siRNA delivery for possible clinical applications, we developed biodegr...
RNA interference (RNAi) is an emerging technology in which the introduction of double-stranded RNA (...
Magister Scientiae - MSc (Pharmaceutical Chemistry)Nanoparticle drug delivery is challenged by the b...
Introduction: The field of RNA interference technology has been researched extensively in recent yea...
Because nanoparticles with diameters less than 50 nm penetrate stromal-rich tumor tissues more effic...
According to the National Institute of Environmental Health Sciences in 2016, more than five million...
Small interfering RNA (siRNA) targeted therapeutics (STT) offers a compelling alternative to traditi...
Copyright © 2012 Haran Yogasundaram et al. This is an open access article distributed under the Crea...
Developing vehicles for the delivery of therapeutic molecules, like siRNA, is an area of active rese...
Developing vehicles for the delivery of therapeutic molecules, like siRNA, is an area of active rese...
Gene regulation through small interfering RNA (siRNA) is a useful way to improve therapeutics and tr...
Therapeutics such as proteins, small interfering RNA (siRNA) and DNA can only exert their function w...
Due to their biodegradable character, polyesters such as polycaprolactone (PCL), poly(D,L-lactide) (...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
The potential of RNA interference (RNAi)-based therapeutics for cancer has received much attention; ...
Purpose: In order to improve siRNA delivery for possible clinical applications, we developed biodegr...
RNA interference (RNAi) is an emerging technology in which the introduction of double-stranded RNA (...
Magister Scientiae - MSc (Pharmaceutical Chemistry)Nanoparticle drug delivery is challenged by the b...
Introduction: The field of RNA interference technology has been researched extensively in recent yea...
Because nanoparticles with diameters less than 50 nm penetrate stromal-rich tumor tissues more effic...
According to the National Institute of Environmental Health Sciences in 2016, more than five million...
Small interfering RNA (siRNA) targeted therapeutics (STT) offers a compelling alternative to traditi...